{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:56:05Z","timestamp":1780322165195,"version":"3.54.1"},"reference-count":44,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There are clinical issues of special importance and practice variation in the management of venous thromboembolism (VTE) and in the use of anticoagulants among hematologists who practice in Asia. In Asian-inherited thrombophilia, coagulation is disturbed due to loss-of-function mutations of protein S and protein C causing protein S and protein C deficiencies, whereas the gain-of-function factor V Leiden and prothrombin G20210A mutations are almost absent. Thrombophilia screening is not recommended in patients with VTE patients who have major provoking factors. However, it can be considered in unprovoked young patients with VTE who have a strong family history of VTE. Cancer is the most important acquired risk factor for VTE in Asians. Limited cancer screening at the initial presentation of unprovoked VTE is appropriate, especially in the elderly. Direct oral anticoagulants have been shown to have similar efficacy and reduce risk of major bleeding, including intracranial hemorrhage and bleeding requiring hospitalization, compared with warfarin. Most clinical trials evaluating therapies for treatment and prevention of VTE have included small numbers of Asian patients. Despite this lack of evidence, direct oral anticoagulants have been increasingly used in Asia for cancer-associated thrombosis. Individualized assessment of thrombotic and bleeding risks should be used for all hospitalized Asian patients when deciding on pharmacologic thromboprophylaxis. More research is needed to understand the factors that contribute to risks of VTE and anticoagulant-associated bleeding in Asian patients as these may differ from Western populations.<\/jats:p>","DOI":"10.1182\/hematology.2022000383","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T16:12:38Z","timestamp":1670602358000},"page":"474-480","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Thrombosis and anticoagulation: clinical issues of special importance to hematologists who practice in Asia"],"prefix":"10.1182","volume":"2022","author":[{"given":"Kochawan","family":"Boonyawat","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantep","family":"Angchaisuksiri","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"12","key":"2022121313294557900_hem2022000383C1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1160\/TH17-02-0134","article-title":"Incidence of venous thromboembolism in Asian populations: a systematic review","volume":"117","author":"Lee","year":"2017","journal-title":"Thromb Haemost"},{"issue":"11","key":"2022121313294557900_hem2022000383C2","doi-asserted-by":"crossref","first-page":"e26861","DOI":"10.1371\/journal.pone.0026861","article-title":"Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008: a multicenter registration study","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"2022121313294557900_hem2022000383C3","first-page":"585","article-title":"Venous thromboembolism in Asia\u2014an unrecognised and under-treated problem?","volume":"106","author":"Angchaisuksiri","year":"2011","journal-title":"Thromb Haemost"},{"issue":"8","key":"2022121313294557900_hem2022000383C4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/rth2.12440","article-title":"Racial differences in protein S Tokushima and two protein C variants as genetic risk factors for venous thromboembolism","volume":"4","author":"Tsuda","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2022121313294557900_hem2022000383C5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"2022121313294557900_hem2022000383C6","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1182\/blood-2008-10-184879","article-title":"Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives","volume":"113","author":"Lijfering","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2022121313294557900_hem2022000383C7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/10245332.2018.1535535","article-title":"Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer","volume":"24","author":"Satpanich","year":"2019","journal-title":"Hematology"},{"issue":"5","key":"2022121313294557900_hem2022000383C8","first-page":"695","article-title":"The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S","volume":"91","author":"De Stefano","year":"2006","journal-title":"Haematologica"},{"issue":"23","key":"2022121313294557900_hem2022000383C9","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1182\/bloodadvances.2020002955","article-title":"Association between congenital thrombophilia and outcomes in pulmonary embolism patients","volume":"4","author":"Lian","year":"2020","journal-title":"Blood Adv"},{"issue":"19","key":"2022121313294557900_hem2022000383C10","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2022121313294557900_hem2022000383C11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02983995","article-title":"Risk factors of venous thromboembolism in Thai patients","volume":"86","author":"Angchaisuksiri","year":"2007","journal-title":"Int J Hematol"},{"key":"2022121313294557900_hem2022000383C12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-017-0155-z","article-title":"The diagnosis and treatment of venous thromboembolism in Asian patients","volume":"16","author":"Wang","year":"2018","journal-title":"Thromb J"},{"key":"2022121313294557900_hem2022000383C13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.thromres.2021.02.024","article-title":"Venous thromboembolism in Asia and worldwide: emerging insights from GARFIELD-VTE","volume":"201","author":"Angchaisuksiri","year":"2021","journal-title":"Thromb Res"},{"issue":"7","key":"2022121313294557900_hem2022000383C14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/qjmed\/hcu023","article-title":"Idiopathic venous thromboembolism: a potential surrogate for occult cancer","volume":"107","author":"Chung","year":"2014","journal-title":"QJM"},{"issue":"8","key":"2022121313294557900_hem2022000383C15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa1506623","article-title":"Screening for occult cancer in unprovoked venous thromboembolism","volume":"373","author":"Carrier","year":"2015","journal-title":"N Engl J Med"},{"key":"2022121313294557900_hem2022000383C16","unstructured":"National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NICE guideline NG158). 2020. https:\/\/www.nice.org.uk\/guidance\/ng158. Accessed 15May2022."},{"issue":"4","key":"2022121313294557900_hem2022000383C17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.annonc.2020.01.008","article-title":"Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS","volume":"31","author":"Park","year":"2020","journal-title":"Ann Oncol"},{"issue":"3","key":"2022121313294557900_hem2022000383C18","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3802\/jgo.2020.31.e55","article-title":"National screening programs for cervical cancer in Asian countries","volume":"31","author":"Aoki","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"2022121313294557900_hem2022000383C19","unstructured":"US Preventive Services Task Force. Colorectal cancer: screening. www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/colorectal-cancer-screening2021. Accessed 18May2022."},{"issue":"3","key":"2022121313294557900_hem2022000383C20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1467-789X.2002.00065.x","article-title":"Asians are different from Caucasians and from each other in their body mass index\/body fat per cent relationship","volume":"3","author":"Deurenberg","year":"2002","journal-title":"Obes Rev"},{"issue":"2","key":"2022121313294557900_hem2022000383C21","doi-asserted-by":"crossref","first-page":"e2036304","DOI":"10.1001\/jamanetworkopen.2020.36304","article-title":"Comparison between non-vitamin k antagonist oral anticoagulants and low-molecular-weight heparin in Asian individuals with cancer-associated venous thromboembolism","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2022121313294557900_hem2022000383C22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022121313294557900_hem2022000383C23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.thromres.2018.04.008","article-title":"Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis","volume":"166","author":"Yamashita","year":"2018","journal-title":"Thromb Res"},{"issue":"2","key":"2022121313294557900_hem2022000383C24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.fpc.0000184955.08453.a8","article-title":"Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans","volume":"16","author":"Takahashi","year":"2006","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"2022121313294557900_hem2022000383C25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/16078454.2021.2019891","article-title":"The efficacy of low-dose warfarin initiation (3\u200amg versus 5\u200amg) in newly diagnosed venous thromboembolism patients among a population with a high prevalence of warfarin-sensitive haplotype of the VKORC1 gene: a randomized controlled trial","volume":"27","author":"Suwanawiboon","year":"2022","journal-title":"Hematology"},{"issue":"11","key":"2022121313294557900_hem2022000383C26","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/STROKEAHA.117.018773","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation","volume":"48","author":"Cha","year":"2017","journal-title":"Stroke"},{"key":"2022121313294557900_hem2022000383C27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2019.09.004","article-title":"Oral anticoagulant-associated bleeding requiring hospitalization in Thai patients: incidences, risk factors, and outcomes","volume":"183","author":"Boonyawat","year":"2019","journal-title":"Thromb Res"},{"issue":"6","key":"2022121313294557900_hem2022000383C28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10557-019-06910-z","article-title":"Real-world comparisons of direct oral anticoagulants for stroke prevention in Asian patients with non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"33","author":"Chan","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"key":"2022121313294557900_hem2022000383C29","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2147\/TCRM.S72268","article-title":"Use of novel oral anticoagulants for the treatment of venous thromboembolism and its considerations in Asian patients","volume":"10","author":"Lee","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"7","key":"2022121313294557900_hem2022000383C30","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/STROKEAHA.113.000990","article-title":"Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation","volume":"44","author":"Hori","year":"2013","journal-title":"Stroke"},{"issue":"6","key":"2022121313294557900_hem2022000383C31","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/STROKEAHA.113.002968","article-title":"Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial","volume":"45","author":"Wong","year":"2014","journal-title":"Stroke"},{"issue":"3","key":"2022121313294557900_hem2022000383C32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2014.06.005","article-title":"Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) Trial","volume":"168","author":"Goto","year":"2014","journal-title":"Am Heart J"},{"issue":"4","key":"2022121313294557900_hem2022000383C33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1253\/circj.CJ-15-1082","article-title":"Edoxaban vs. warfarin in East Asian patients with atrial fibrillation\u2014An ENGAGE AF-TIMI 48 subanalysis","volume":"80","author":"Yamashita","year":"2016","journal-title":"Circ J"},{"issue":"6","key":"2022121313294557900_hem2022000383C34","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1253\/circj.CJ-15-0195","article-title":"Apixaban for the treatment of japanese subjects with acute venous thromboembolism (AMPLIFY-J study)","volume":"79","author":"Nakamura","year":"2015","journal-title":"Circ J"},{"key":"2022121313294557900_hem2022000383C35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12959-015-0035-3","article-title":"Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism\u2014the J-EINSTEIN DVT and PE program","volume":"13","author":"Yamada","year":"2015","journal-title":"Thromb J"},{"issue":"4","key":"2022121313294557900_hem2022000383C36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.blre.2017.02.001","article-title":"Old and new oral anticoagulants: food, herbal medicines and drug interactions","volume":"31","author":"Di Minno","year":"2017","journal-title":"Blood Rev"},{"key":"2022121313294557900_hem2022000383C37","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.15420\/ecr.2020.43","article-title":"Direct oral anticoagulants in Asian patients with atrial fibrillation: consensus recommendations by the Asian Pacific Society of Cardiology on strategies for thrombotic and bleeding risk management","volume":"16","author":"Chong","year":"2021","journal-title":"Eur Cardiol"},{"issue":"6","key":"2022121313294557900_hem2022000383C38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jjcc.2015.03.012","article-title":"Current management of venous thromboembolism in Japan: current epidemiology and advances in anticoagulant therapy","volume":"66","author":"Nakamura","year":"2015","journal-title":"J Cardiol"},{"issue":"4","key":"2022121313294557900_hem2022000383C39","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/j.thromres.2012.01.012","article-title":"Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study","volume":"129","author":"Parikh","year":"2012","journal-title":"Thromb Res"},{"issue":"4","key":"2022121313294557900_hem2022000383C40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MBC.0b013e328338dbfa","article-title":"High incidence of symptomatic venous thromboembolism in Thai hospitalized medical patients without thromboprophylaxis","volume":"21","author":"Aniwan","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"22","key":"2022121313294557900_hem2022000383C41","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"key":"2022121313294557900_hem2022000383C42","doi-asserted-by":"crossref","first-page":"100054","DOI":"10.1016\/j.lanwpc.2020.100054","article-title":"DissolVE-2 investigators. Validation of the IMPROVE bleeding risk score in Chinese medical patients during hospitalization: findings from the dissolve-2 study","volume":"4","author":"Zhang","year":"2020","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"2022121313294557900_hem2022000383C43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23736\/S0392-9590.16.03765-2","article-title":"Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism","volume":"36","author":"Liew","year":"2017","journal-title":"Int Angiol"},{"issue":"6","key":"2022121313294557900_hem2022000383C44","first-page":"526","article-title":"A survey of contemporary opinions and practices of surgical and intensive care specialists towards peri-operative venous thromboembolism prophylaxis in Asia","volume":"31","author":"Lee","year":"2012","journal-title":"Int Angiol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/474\/2023018\/474boonyawat.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2022\/1\/474\/2023018\/474boonyawat.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T13:33:57Z","timestamp":1670938437000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2022\/1\/474\/493546\/Thrombosis-and-anticoagulation-clinical-issues-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2022,12,9]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2022000383","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,9]]},"published":{"date-parts":[[2022,12,9]]}}}